FDA panel backs Pfizer's drug for kidney cancer

Pfizer Inc won unanimous expert backing for its Inlyta experimental drug for patients with advanced kidney cancer.

View full post on Yahoo! Health News

, , , , ,

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Get Adobe Flash player

Powered by Yahoo! Answers

© 1992-2012 DC2NET™, Inc. All Rights Reserved